Global Mefloquine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Get Access Now!

Global Mefloquine Size, Trends and Analysis 2025-31

The global Mefloquine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Mefloquine, a 4-quinolinemethanol compound, is an important antimalarial drug. It inhibits the growth of Plasmodium by disrupting mitochondrial function and DNA replication. With broad antimalarial activity against various Plasmodium species, including P. falciparum and P. vivax, it is well-absorbed orally, has a long half-life, and offers enduring efficacy. For prevention, weekly dosing suffices, while treatment requires only a short course. Widely used in malaria-endemic areas, it is especially valuable for chloroquine-resistant Plasmodium infections. It can also be combined with other antimalarials to enhance efficacy and delay resistance. However, mefloquine use is restricted due to potential severe neurological side effects like dizziness, insomnia, and anxiety, and rare but serious reactions such as psychiatric changes or arrhythmias. Risk-benefit evaluation and strict adherence to medical advice are essential for safe use. Market Development Opportunities & Main Driving Factors Mefloquine market growth is driven by malaria prevalence and rising drug resistance. In malaria-endemic regions like Africa and Southeast Asia, increasing chloroquine resistance boosts mefloquine demand as an alternative. Climate change and population movements are expanding malarias reach, further driving mefloquine need. Its preventive advantages make it a top choice for travelers and military personnel heading to high-risk malaria areas. Recent studies suggest mefloquines potential for greater role in combination therapies, creating new market opportunities. Also, public health policies in many countries support mefloquine use to combat malaria. Market Challenges, Risks, & Restraints Yet, the mefloquine market faces challenges. Its side effects, particularly severe neurological and psychiatric reactions, have led to stringent usage restrictions by many drug regulators, limiting demand. Also, it competes with multiple antimalarials like artemisinin-based combinations, each with their efficacy and safety advantages. Mefloquine must enhance cost-effectiveness and market recognition. Its complex production process, requiring advanced technology and equipment, raises costs and market entry barriers. Finally, growing Plasmodium resistance to mefloquine threatens its long-term competitiveness. Downstream Demand Trends For downstream demand, malaria treatment and prevention are the main mefloquine application fields. In treatment, rising Plasmodium resistance to traditional drugs keeps mefloquine relevant as a second-line therapy, especially in high-burden African and Southeast Asian regions. In prevention, rising international travel and business activities increase the number of people visiting malaria-endemic areas, providing steady growth for mefloquines preventive use. In the military sector, it remains crucial for protecting troops in high-risk areas. However, awareness of its side effects may reduce its preventive market share, confining its future use to tolerant specific groups. New antimalarials and vaccines could also squeeze its market share, but mefloquine will retain irreplaceability in certain regions and groups. Infinity Market Research newest research report, the Mefloquine Industry Forecast looks at past sales and reviews total world Mefloquine sales in 2024, providing a comprehensive analysis by region and market sector of projected Mefloquine sales for 2025 through 2031. With Mefloquine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mefloquine industry. This Insight Report provides a comprehensive analysis of the global Mefloquine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mefloquine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Mefloquine market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mefloquine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mefloquine. This report presents a comprehensive overview, market shares, and growth opportunities of Mefloquine market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Purity 98% &nbsp;&nbsp;&nbsp; Purity 99% &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Chemical Industry &nbsp;&nbsp;&nbsp; Pharmaceutical Industry This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Toronto Research Chemicals &nbsp;&nbsp;&nbsp; Alfa Chemistry &nbsp;&nbsp;&nbsp; Waterstone Technology &nbsp;&nbsp;&nbsp; 2A PharmaChem &nbsp;&nbsp;&nbsp; 3B Scientific &nbsp;&nbsp;&nbsp; Chembest Research Laboratories &nbsp;&nbsp;&nbsp; Ningbo Taikang Chemical &nbsp;&nbsp;&nbsp; Hangzhou J&H Chemical &nbsp;&nbsp;&nbsp; Advanced Technology & Industrial &nbsp;&nbsp;&nbsp; GlaxoSmithKline &nbsp;&nbsp;&nbsp; Bayer &nbsp;&nbsp;&nbsp; Novartis &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Hoffmann-La Roche &nbsp;&nbsp;&nbsp; Cipla &nbsp;&nbsp;&nbsp; Mylan &nbsp;&nbsp;&nbsp; Ipca Laboratories Key Questions Addressed in this Report What is the 10-year outlook for the global Mefloquine market? What factors are driving Mefloquine market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Mefloquine market opportunities vary by end market size? How does Mefloquine break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Mefloquine Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Mefloquine by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Mefloquine by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Mefloquine Segment by Type &nbsp;2.2.1 Purity 98% &nbsp;2.2.2 Purity 99% &nbsp;2.2.3 Others &nbsp;2.3 Mefloquine Sales by Type &nbsp;2.3.1 Global Mefloquine Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Mefloquine Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Mefloquine Sale Price by Type (2020-2025) &nbsp;2.4 Mefloquine Segment by Application &nbsp;2.4.1 Chemical Industry &nbsp;2.4.2 Pharmaceutical Industry &nbsp;2.5 Mefloquine Sales by Application &nbsp;2.5.1 Global Mefloquine Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Mefloquine Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Mefloquine Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Mefloquine Breakdown Data by Company &nbsp;3.1.1 Global Mefloquine Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Mefloquine Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Mefloquine Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Mefloquine Revenue by Company (2020-2025) &nbsp;3.2.2 Global Mefloquine Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Mefloquine Sale Price by Company &nbsp;3.4 Key Manufacturers Mefloquine Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Mefloquine Product Location Distribution &nbsp;3.4.2 Players Mefloquine Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Mefloquine by Geographic Region &nbsp;4.1 World Historic Mefloquine Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Mefloquine Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Mefloquine Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Mefloquine Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Mefloquine Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Mefloquine Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Mefloquine Sales Growth &nbsp;4.4 APAC Mefloquine Sales Growth &nbsp;4.5 Europe Mefloquine Sales Growth &nbsp;4.6 Middle East & Africa Mefloquine Sales Growth 5 Americas &nbsp;5.1 Americas Mefloquine Sales by Country &nbsp;5.1.1 Americas Mefloquine Sales by Country (2020-2025) &nbsp;5.1.2 Americas Mefloquine Revenue by Country (2020-2025) &nbsp;5.2 Americas Mefloquine Sales by Type (2020-2025) &nbsp;5.3 Americas Mefloquine Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Mefloquine Sales by Region &nbsp;6.1.1 APAC Mefloquine Sales by Region (2020-2025) &nbsp;6.1.2 APAC Mefloquine Revenue by Region (2020-2025) &nbsp;6.2 APAC Mefloquine Sales by Type (2020-2025) &nbsp;6.3 APAC Mefloquine Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Mefloquine by Country &nbsp;7.1.1 Europe Mefloquine Sales by Country (2020-2025) &nbsp;7.1.2 Europe Mefloquine Revenue by Country (2020-2025) &nbsp;7.2 Europe Mefloquine Sales by Type (2020-2025) &nbsp;7.3 Europe Mefloquine Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Mefloquine by Country &nbsp;8.1.1 Middle East & Africa Mefloquine Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Mefloquine Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Mefloquine Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Mefloquine Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Mefloquine &nbsp;10.3 Manufacturing Process Analysis of Mefloquine &nbsp;10.4 Industry Chain Structure of Mefloquine 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Mefloquine Distributors &nbsp;11.3 Mefloquine Customer 12 World Forecast Review for Mefloquine by Geographic Region &nbsp;12.1 Global Mefloquine Market Size Forecast by Region &nbsp;12.1.1 Global Mefloquine Forecast by Region (2026-2031) &nbsp;12.1.2 Global Mefloquine Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Mefloquine Forecast by Type (2026-2031) &nbsp;12.7 Global Mefloquine Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Toronto Research Chemicals &nbsp;13.1.1 Toronto Research Chemicals Company Information &nbsp;13.1.2 Toronto Research Chemicals Mefloquine Product Portfolios and Specifications &nbsp;13.1.3 Toronto Research Chemicals Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Toronto Research Chemicals Main Business Overview &nbsp;13.1.5 Toronto Research Chemicals Latest Developments &nbsp;13.2 Alfa Chemistry &nbsp;13.2.1 Alfa Chemistry Company Information &nbsp;13.2.2 Alfa Chemistry Mefloquine Product Portfolios and Specifications &nbsp;13.2.3 Alfa Chemistry Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Alfa Chemistry Main Business Overview &nbsp;13.2.5 Alfa Chemistry Latest Developments &nbsp;13.3 Waterstone Technology &nbsp;13.3.1 Waterstone Technology Company Information &nbsp;13.3.2 Waterstone Technology Mefloquine Product Portfolios and Specifications &nbsp;13.3.3 Waterstone Technology Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Waterstone Technology Main Business Overview &nbsp;13.3.5 Waterstone Technology Latest Developments &nbsp;13.4 2A PharmaChem &nbsp;13.4.1 2A PharmaChem Company Information &nbsp;13.4.2 2A PharmaChem Mefloquine Product Portfolios and Specifications &nbsp;13.4.3 2A PharmaChem Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 2A PharmaChem Main Business Overview &nbsp;13.4.5 2A PharmaChem Latest Developments &nbsp;13.5 3B Scientific &nbsp;13.5.1 3B Scientific Company Information &nbsp;13.5.2 3B Scientific Mefloquine Product Portfolios and Specifications &nbsp;13.5.3 3B Scientific Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 3B Scientific Main Business Overview &nbsp;13.5.5 3B Scientific Latest Developments &nbsp;13.6 Chembest Research Laboratories &nbsp;13.6.1 Chembest Research Laboratories Company Information &nbsp;13.6.2 Chembest Research Laboratories Mefloquine Product Portfolios and Specifications &nbsp;13.6.3 Chembest Research Laboratories Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Chembest Research Laboratories Main Business Overview &nbsp;13.6.5 Chembest Research Laboratories Latest Developments &nbsp;13.7 Ningbo Taikang Chemical &nbsp;13.7.1 Ningbo Taikang Chemical Company Information &nbsp;13.7.2 Ningbo Taikang Chemical Mefloquine Product Portfolios and Specifications &nbsp;13.7.3 Ningbo Taikang Chemical Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Ningbo Taikang Chemical Main Business Overview &nbsp;13.7.5 Ningbo Taikang Chemical Latest Developments &nbsp;13.8 Hangzhou J&H Chemical &nbsp;13.8.1 Hangzhou J&H Chemical Company Information &nbsp;13.8.2 Hangzhou J&H Chemical Mefloquine Product Portfolios and Specifications &nbsp;13.8.3 Hangzhou J&H Chemical Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Hangzhou J&H Chemical Main Business Overview &nbsp;13.8.5 Hangzhou J&H Chemical Latest Developments &nbsp;13.9 Advanced Technology & Industrial &nbsp;13.9.1 Advanced Technology & Industrial Company Information &nbsp;13.9.2 Advanced Technology & Industrial Mefloquine Product Portfolios and Specifications &nbsp;13.9.3 Advanced Technology & Industrial Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Advanced Technology & Industrial Main Business Overview &nbsp;13.9.5 Advanced Technology & Industrial Latest Developments &nbsp;13.10 GlaxoSmithKline &nbsp;13.10.1 GlaxoSmithKline Company Information &nbsp;13.10.2 GlaxoSmithKline Mefloquine Product Portfolios and Specifications &nbsp;13.10.3 GlaxoSmithKline Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 GlaxoSmithKline Main Business Overview &nbsp;13.10.5 GlaxoSmithKline Latest Developments &nbsp;13.11 Bayer &nbsp;13.11.1 Bayer Company Information &nbsp;13.11.2 Bayer Mefloquine Product Portfolios and Specifications &nbsp;13.11.3 Bayer Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Bayer Main Business Overview &nbsp;13.11.5 Bayer Latest Developments &nbsp;13.12 Novartis &nbsp;13.12.1 Novartis Company Information &nbsp;13.12.2 Novartis Mefloquine Product Portfolios and Specifications &nbsp;13.12.3 Novartis Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Novartis Main Business Overview &nbsp;13.12.5 Novartis Latest Developments &nbsp;13.13 Pfizer &nbsp;13.13.1 Pfizer Company Information &nbsp;13.13.2 Pfizer Mefloquine Product Portfolios and Specifications &nbsp;13.13.3 Pfizer Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.13.4 Pfizer Main Business Overview &nbsp;13.13.5 Pfizer Latest Developments &nbsp;13.14 Hoffmann-La Roche &nbsp;13.14.1 Hoffmann-La Roche Company Information &nbsp;13.14.2 Hoffmann-La Roche Mefloquine Product Portfolios and Specifications &nbsp;13.14.3 Hoffmann-La Roche Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.14.4 Hoffmann-La Roche Main Business Overview &nbsp;13.14.5 Hoffmann-La Roche Latest Developments &nbsp;13.15 Cipla &nbsp;13.15.1 Cipla Company Information &nbsp;13.15.2 Cipla Mefloquine Product Portfolios and Specifications &nbsp;13.15.3 Cipla Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.15.4 Cipla Main Business Overview &nbsp;13.15.5 Cipla Latest Developments &nbsp;13.16 Mylan &nbsp;13.16.1 Mylan Company Information &nbsp;13.16.2 Mylan Mefloquine Product Portfolios and Specifications &nbsp;13.16.3 Mylan Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.16.4 Mylan Main Business Overview &nbsp;13.16.5 Mylan Latest Developments &nbsp;13.17 Ipca Laboratories &nbsp;13.17.1 Ipca Laboratories Company Information &nbsp;13.17.2 Ipca Laboratories Mefloquine Product Portfolios and Specifications &nbsp;13.17.3 Ipca Laboratories Mefloquine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.17.4 Ipca Laboratories Main Business Overview &nbsp;13.17.5 Ipca Laboratories Latest Developments 14 Research Findings and Conclusion

Report	Global Mefloquine Market Growth 2025-2031
Selected License	Multi ID: LPI28366

Buyer Information

Order Summary